AbbVie Inc.
$503.16B- Market cap
- $443.39B
- Debt
- +$65.00B
- Cash
- −$5.23B
Capital structure 87% equity / 13% debt · EV / Revenue 8.23x · EV proxy / EBITDA proxy 21.67x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ABBV · price snapshotP/E 106.32x
$250.91Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at BIO's multiple
$31.9487.3% below market
2.36 ABBV Annual EPS×13.54x BIO P/E=$31.94
Market $250.91Implied $31.94
BIO · price snapshotP/E 13.54x
$376.97Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at ABBV's multiple
$2,960.95685.5% above market
27.85 BIO Annual EPS×106.32x ABBV P/E=$2,960.95
Market $376.97Implied $2,960.95